Genmab A-S
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $1,187,000 | $1,155,000 | $899,315 | $1,054,810 |
Gross Profit | 1,099,000 | 1,071,000 | 834,075 | 974,054 |
EBITDA | 492,000 | 431,000 | 186,688 | 98,701 |
EBIT | 465,000 | 405,000 | 186,000 | 99,000 |
Net Income | 342,000 | 303,000 | 53,196 | 30,906 |
Net Change In Cash | 1,187,000 | 1,155,000 | 899,315 | 1,054,810 |
Free Cash Flow | 509,000 | 48,000 | -2,007 | 287,351 |
Cash | 1,860,000 | 1,503,000 | 1,520,975 | 1,711,087 |
Basic Shares | 620,690 | 617,107 | 638,554 | 672,593 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,722,933 | $21,526,000 | $16,474,000 | $14,505,000 |
Gross Profit | 3,413,690 | 20,541,000 | 16,248,000 | 14,505,000 |
EBITDA | 1,337,053 | 9,697,000 | 6,000,618 | 7,346,000 |
EBIT | 1,265,997 | 9,284,000 | 5,707,000 | 6,984,000 |
Net Income | 963,759 | 7,844,000 | 4,352,000 | 5,452,000 |
Net Change In Cash | 3,722,933 | 21,526,000 | 16,474,000 | 14,505,000 |
Free Cash Flow | 1,149,906 | 7,584,000 | 7,004,000 | 3,595,000 |
Cash | 1,711,087 | 9,858,000 | 14,867,000 | 9,893,000 |
Basic Shares | 626,916 | 646,330 | 659,150 | 660,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $0.56 |
2026-06-30 | $0.54 |
2026-03-31 | $0.13 |
2025-12-31 | $0.21 |